Drugs Recalls

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Failed Dissolution Specifications: Pfizer Inc. is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the dissolution specification for conjugated estrogens.

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes